Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

NORWOOD
Norwood Financial declares $0.32 per share quarterly cash dividend

Norwood Financial Corp's board declared a $0.32 per share cash dividend payable August 3, 2026, maintaining the same quarterly payout as Q1 2026. The ...

ALLSTATE
Allstate reports $289M catastrophe losses for May 2026

Allstate Corporation announced estimated catastrophe losses of $289 million ($228 million after-tax) for May 2026, with combined April-May losses tota...

STOREBRAND
13F-HR - STOREBRAND ASSET MANAGEMENT AS (0001685676) (Filer)

Institutional holdings report (13F-HR) filed by STOREBRAND ASSET MANAGEMENT AS....

STOREBRAND
13F-HR - STOREBRAND ASSET MANAGEMENT AS (0001685676) (Filer)

Institutional holdings report (13F-HR) filed by STOREBRAND ASSET MANAGEMENT AS....

STOREBRAND
13F-HR - STOREBRAND ASSET MANAGEMENT AS (0001685676) (Filer)

Institutional holdings report (13F-HR) filed by STOREBRAND ASSET MANAGEMENT AS....

Chicago
Chicago Atlantic Real Estate Finance agrees to merge with Chicago Atlantic BDC

Chicago Atlantic Real Estate Finance, Inc. has entered into an Agreement and Plan of Merger with Chicago Atlantic BDC, Inc., effective June 17, 2026. ...

ADVANCED
ADS hosts 2026 Investor Day, unveils fiscal 2030 outlook

Advanced Drainage Systems held its 2026 Investor Day at its new Engineering and Technology Center in Hilliard, Ohio, where leadership presented update...

STOREBRAND
13F-HR - STOREBRAND ASSET MANAGEMENT AS (0001685676) (Filer)

Institutional holdings report (13F-HR) filed by STOREBRAND ASSET MANAGEMENT AS....

STOREBRAND
13F-HR - STOREBRAND ASSET MANAGEMENT AS (0001685676) (Filer)

Institutional holdings report (13F-HR) filed by STOREBRAND ASSET MANAGEMENT AS....

STOREBRAND
13F-HR - STOREBRAND ASSET MANAGEMENT AS (0001685676) (Filer)

Institutional holdings report (13F-HR) filed by STOREBRAND ASSET MANAGEMENT AS....

ENANTA
Enanta advances zelicapavir into Phase 2b/3 RSV trial following FDA meeting

Enanta Pharmaceuticals announced advancement of zelicapavir into a registrational Phase 2b/3 clinical trial for high-risk RSV adults, with Phase 2b da...

STOREBRAND
13F-HR - STOREBRAND ASSET MANAGEMENT AS (0001685676) (Filer)

Institutional holdings report (13F-HR) filed by STOREBRAND ASSET MANAGEMENT AS....

DELUXE
Deluxe Corp agrees to be acquired by LLR Payments and affiliates

Deluxe Corporation has entered into an Equity Purchase Agreement and Plan of Merger with LLR V Payments LLC and related entities. The transaction repr...

PFIZER
Pfizer CFO Dave Denton to depart August 15; Cecile Guegan named interim CFO

Pfizer Chief Financial Officer Dave Denton is stepping down on August 15, 2026 to pursue an opportunity in consumer goods, with Senior Vice President ...

Green
Green Thumb Industries files amended and restated articles of incorporation

Green Thumb Industries Inc. has filed amended and restated articles of incorporation with updated governance provisions. The filing outlines standard ...

KIORA
Kiora's KIO-300 suppresses seizure activity in preclinical epilepsy model

Kiora Pharmaceuticals announced preclinical data showing KIO-300 significantly reduced seizure-associated activity in a temporal lobe epilepsy model, ...

Ambow
Ambow Education launches HybriU ProjectHub, AI-powered collaboration platform

Ambow Education announced the launch of HybriU ProjectHub, a centralized project collaboration platform featuring AI-assisted summaries and role-based...

Chicago
Chicago Atlantic BDC to merge with Chicago Atlantic Real Estate Finance

Chicago Atlantic BDC, Inc. has entered into an Agreement and Plan of Merger with Chicago Atlantic Real Estate Finance, Inc., effective June 17, 2026. ...

D-Wave
D-Wave announces first gate-model quantum computing simulator for error-aware programming

D-Wave unveiled a forthcoming gate-model quantum simulator designed for error-aware programming, with access beginning September 2026 through new deve...

NovoCure
NovoCure's Phase 3 TRIDENT trial misses primary endpoint for earlier TTFields therapy

NovoCure announced topline results from its Phase 3 TRIDENT trial evaluating earlier initiation of Tumor Treating Fields therapy in newly diagnosed gl...